Spinal Cord Stimulation Devices Market Landscape 2025: Forecast Data and Growth Strategy Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Spinal Cord Stimulation Devices Market Through 2025?
The market for spinal cord stimulation devices has seen a robust expansion in the recent past. Its size is projected to increase from $2.74 billion in 2024 to $2.97 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. The historical growth surge is linked to enhancements in clinical results and patient satisfaction, heightened awareness of alternatives for pain management, a swell in support for reimbursement, an increase in clinical studies and regulatory approvals, along with the development of pain management clinics and centers.

What's the Projected Size of the Global Spinal Cord Stimulation Devices Market by 2029?
Strong growth is projected for the spinal cord stimulation devices market in the coming years, with an anticipated increase expected to reach $4.13 billion by 2029, boasting a compound annual growth rate (CAGR) of 8.6%. This growth forecast is attributed to a variety of factors including an increase in chronic pain conditions, a surge in demand for non-opioid pain management alternatives, a growing elderly population, favorable reimbursement policies, a rise in the usage of wireless and rechargeable devices, and enhanced awareness about neuromodulation therapies among both healthcare professionals and patients. The forecast period is set to feature major trends such as improvement in minimally invasive technologies, advancement in wireless and rechargeable devices, development in frequency stimulation, acceptance of closed-loop feedback systems, wireless connectivity integration, advanced waveform options, and tailored pain management algorithms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-devices-global-market-report

Top Growth Drivers in the Spinal Cord Stimulation Devices Industry: What's Accelerating the Market?
The growth of the spinal cord stimulation devices market is projected to be propelled by the increasing prevalence of chronic pain instances. In cases such as arthritis, neuropathy, and lower back pain, chronic pain refers to constant pain that persists for 12 weeks or more. Several factors contribute to the increase in chronic pain cases, including an ageing population, lifestyle modifications, chronic health problems, and injury or trauma. Spinal cord stimulation (SCS) devices mitigate chronic pain by modifying pain signals with electric impulses, helping manage persistent conditions. For example, data from the Centers for Disease Control and Prevention, a US-based governmental organization, showed that in 2023, 24.3% of adults reported chronic pain, with 8.5% of them experiencing severe chronic pain. This accounted for 34.9% of those suffering from chronic pain. As a result, the increasing prevalence of chronic pain is spurring the growth of the spinal cord stimulation devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20964&type=smp

Which Emerging Trends Are Transforming the Spinal Cord Stimulation Devices Market in 2025?
Leading firms active in the spinal cord stimulation devices market are concentrating on the creation of innovative technologies like rechargeable spinal cord stimulation systems. Their aim is to better patient results, extend device lifespan, and offer more customized pain relief alternatives for those dealing with chronic pain. Rechargeable spinal cord stimulation (SCS) systems are advanced medical instruments engineered to manage chronic pain by delivering electrical impulses to the spinal cord. Take Abbott Laboratories, an American medical devices manufacturer as an example. In December 2022, they obtained the US Food and Drug Administration (FDA)'s approval for their Eterna spinal cord stimulation (SCS) system, a revolutionary approach to chronic pain control. This inventive gadget combines a sleek design with high-end functionality, bringing improved comfort and lesser physical load for patients. The system's rechargeability ensures long-term use, thereby minimizing the necessity for surgical replacements and providing convenience. The system comes with accurate stimulation features, enabling personalized pain relief customized to the individual patient's requirements. Its sleek design promotes minimally invasive implantation procedures, curtails recovery time, and enhances overall patient outcomes.

What Are the Main Segments in the Spinal Cord Stimulation Devices Market?
The spinal cord stimulation devices market covered in this report is segmented -

1) By Type: Implantable Spinal Cord Stimulators, Non-Implantable Spinal Cord Stimulators
2) By Product Type: Rechargeable Devices, Non-Rechargeable Devices
3) By Application: Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Degenerative Disc Disease, Unsuccessful Disk Surgery, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Neuro Clinics

Subsegments:
1) By Implantable Spinal Cord Stimulators: Rechargeable Spinal Cord Stimulators, Non-Rechargeable Spinal Cord Stimulators, Multi-Lead Implantable Spinal Cord Stimulators
2) By Non-Implantable Spinal Cord Stimulators: External Spinal Cord Stimulators, Wearable Spinal Cord Stimulators, Transcutaneous Spinal Cord Stimulators

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20964&type=smp

Which Top Companies are Driving Growth in the Spinal Cord Stimulation Devices Market?
Major companies operating in the spinal cord stimulation devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nevro Corp., Bluewind Medical, NeuroPace Inc., Vertos Medical Inc., SPR Therapeutics Inc., Saluda Medical Pty Ltd., Stimwave Technologies Inc., Nuvectra Inc., Soterix Medical Inc., Synapse Biomedical, ONWARD Medical NV, NeuroSigma Inc., Nalu Medical Inc., Neurostim Technologies, SpineX Inc., Aleva Neurotherapeutics SA, GTX Medical BV

Which Regions Will Dominate the Spinal Cord Stimulation Devices Market Through 2029?
North America was the largest region in the spinal cord stimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20964

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.